ArticleInfection and drug resistance2026
Pathogenic Characteristics and Molecular Epidemiological Analysis of
Article in Infection and drug resistance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Methods: In this study, we isolated KP strains from UTI patients and performed antimicrobial susceptibility testing, whole-genome sequencing (WGS), and comprehensive genomic analyses to delineate their molecular characteristics. Results: Multilocus sequence typing (MLST) identified 41 sequence types (STs), with ST11 being the most prevalent. Phylogenetic analysis revealed that most local strains clustered closely with the globally disseminated KP clonal group 258 (CG258), suggesting a potential origin from this epidemic lineage. All isolates carried virulence and antibiotic resistance genes, with ST11 strains exhibiting the highest resistance gene burden, classifying them as multidrug-resistant (MDR). We further characterized the plasmid pNDM-MAR and identified biosynthetic gene clusters (BGCs) for redox-cofactors, azole-containing RiPPs, terpene precursors, NRP-metallophores, type I polyketide synthases (T1PKS), RiPP-like compounds, and non-ribosomal peptide synthetase-independent siderophores (NI-siderophores). Discussion: These findings underscore the convergence of hypervirulence and multidrug resistance in KP, highlighting the need for continuous genomic surveillance to inform infection control strategies and antimicrobial stewardship.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.